Currently, 14 billion opioid doses are put on the U.S. market each year — enough for every adult American to have a one month’s prescription of addictive painkillers. WASHINGTON –(ENEWSPF)—March 12, 2018 By: Rosemary Piser The United State is in the midst of a prescription opioid, heroin, and fentanyl crisis[Read More…]
Health and Fitness
Red-state Changes Could Strengthen Affordable Care Act, Medicaid
Washington, DC—(ENEWSPF)—March 12, 2018 By: Drew Altman, Kaiser Family Foundation By making their Affordable Care Act marketplaces and Medicaid programs more conservative, the leaders of several red states may actually strengthen the Affordable Care Act (ACA) and Medicaid by creating a stronger Republican constituency for both programs. The bottom line:[Read More…]
Study: Cannabis Effective At Treating Symptoms Of Fibromyalgia
Netanya, Israel—(ENEWSPF)—March 9, 2018 By: Paul Armentano, NORML Deputy Director Cannabis therapy mitigates symptoms of the chronic pain condition fibromyalgia and is associated with a reduction in the use of other prescription drugs, according to clinical data published online ahead of print in the Journal of Clinical Rheumatology. An estimated[Read More…]
Jury’s In: Opioids Are Not Better Than Other Medicines For Chronic Pain
CALIFORNIA—(ENEWSPF)—March 9, 2018 By: Alex Smith, KCUR A few years ago, Renea Molden’s doctors told her they wanted to take her off her opioid pills. It did not sound like good idea to her. “I was mad, I’ll be honest. I was mad. I was frustrated,” said Molden, 40, of[Read More…]
FDA Approves First Tests to Screen for Tickborne Parasite in Whole Blood and Plasma
Silver Spring, Maryland—(ENEWSPF)—March 8, 2018 By: Megan McSeveney Food and Drug Administration (FDA) approved the Imugen Babesia microti Arrayed Fluorescent Immunoassay (AFIA), for the detection of antibodies to Babesia microti (B. microti) in human plasma samples, and the Imugen Babesia microti Nucleic Acid Test (NAT), for the detection of B.[Read More…]
FDA Approves New HIV Treatment for Patients With Limited Treatment Options
Silver Spring, Maryland—(ENEWSPF)—March 8, 2018 By: Theresa Eisenman The U.S. Food and Drug Administration (FDA) approved Trogarzo (ibalizumab-uiyk), a new type of antiretroviral medication for adult patients living with HIV who have tried multiple HIV medications in the past (heavily treatment-experienced) and whose HIV infections cannot be successfully treated with[Read More…]
Kodiak Cakes Issues Allergy Alert for Certain Blueberry Chia Energy Waffles
Silver Spring, Maryland—(ENEWSPF)—March 8, 2018 By: Rosemary Piser The Food and Drug Administration (FDA) reports that Kodiak Cakes of Park City, UT is recalling all lots and codes of Kodiak Cakes Blueberry Chia Energy Waffles. The recalled 10.72 ounce waffles were on the shelf prior to March 5, 2018 and[Read More…]
FDA Expands Approval of Replacement Heart Valve
Smallest mechanical valve size approved in the world Silver Spring, Maryland—(ENEWSPF)—March 8, 2018 By: Rosemary Piser The Food and Drug Administration (FDA) announced that is has expanded the approval of a heart valve about the size of a dime that can be used to treat heart defects in newborn pediatric[Read More…]
FDA Authorizes Consumer Test that Reports Three Mutations in the BRCA Breast Cancer Genes
Test only reports 3 out of more than 1,000 known BRCA mutations and negative result doesn’t rule out increased cancer risk Silver Spring, Maryland—(ENEWSPF)—March 6, 2018 By: Rosemary Piser The Food and Drug Administration (FDA) has authorized the Personal Genome Service Genetic Health Risk (GHR) Report for BRCA1/BRCA2 (Selected Variants).[Read More…]
Attorney General Madigan Joins 15 Attorneys General to Defend Women’s Constitutionally Protected Reproductive Rights
Attorneys General Oppose Four Arkansas State Laws that Severely Curtail Access to Abortion Services Chicago —(ENEWSPF)—March 2, 2018 By: Rosemary Piser Attorney General Madigan joined 15 other Attorneys General yesterday to defend women’s access to constitutionally protected reproductive rights. An amicus brief was filed with the U.S. Court of Appeals for[Read More…]
